SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

Nepal has confirmed two additional cases of mpox among migrant workers, according to health authorities on Friday. With the ...

A new laboratory has been created in Wiltshire to boost the UK's ability to fight future pandemics. The Diagnostic ...

New research led by scientists at La Jolla Institute for Immunology (LJI) suggests that many people already have immune cells ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

SIGA Technologies (SIGA) stock gains as Japan approves antiviral Tepoxx as a treatment for orthopoxviruses including mpox.

The Department of Health (DOH) prioritized projects promoting primary and emergency care, and local health systems in 2024, ...

The Ministry of Health has urged Kenyans to exercise caution amid a new wave of MPOX infections spreading rapidly across the ...

It was a year in health news that will be hard to forget.As blockbuster weight-loss drugs known as GLP-1s made a sizab ...

The year 2024 was pivotal for Kenya’s healthcare sector, marked by ambitious reforms and persistent challenges. Key ...

Two deaths from Nipah virus, a zoonotic pathogen with a high mortality rate, were reported in Kerala, India in June and ...